Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 December 2018 | Story Leonie Bolleurs | Photo Sonia Small
David Abbey
David Abbey is also serving on the UFS Council’s Finance, Audit, Risk and IT Governance Committee.

David Abbey, a senior banker and transactor in the Acquisition and Leveraged Finance Division at Rand Merchant Bank in Johannesburg, was appointed to the UFS Council.

An undergraduate student of Rhodes University, David is also a proud product of the UFS, having completed his Accounting honours degree at this university. For the past few years, he has also guest lectured on investment banking and financial instruments to Accounting honours students as part of the PwC Financial Instruments Programme.

Large-scale impact

Therefore, his appointment to the Council is particularly special to him.

“Being a member of the Council gives me the platform to have a more large-scale impact on the institution, academic community, the economy, and society. I’m thrilled to be serving alongside an astute body of incredible individuals from whom I will undoubtedly learn,” he says.

Realising his full potential

David is serving on the Council’s Finance, Audit, Risk and IT Governance Committee and his experience in, and knowledge of finance, technology, and audit skills will stand him in good stead. When he’s not developing and structuring innovative, multidisciplinary, and integrated financial solutions for his corporate clients, he loves to be active. He is a regular gym-goer and plays and watches all kinds of sport. Travel, the arts, and motoring are some of his other passions. 

On a personal level, there is still much he wants to achieve. “I want to continue to work hard, using my God-given talents to realise my full potential and to make a humble mark in society and in people’s lives.”

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept